Roche Alzheimer's study fails in another setback to a long-tested hypothesis

Retrieved on: 2022-06-16 16:15:30

Tags for this article:

Monoclonal antibodies

Life Sciences

Treatment of Alzheimer's disease

Spinal muscular atrophy

Crenezumab

Aducanumab

Amyloid beta

Click the tags to see associated articles and topics

Roche Alzheimer's study fails in another setback to a long-tested hypothesis. View article details on HISWAI: https://www.biopharmadive.com/news/roche-alzheimers-crenezumab-colombia-study-failure/625640/

Excerpt

Roche's announcement may therefore add to concerns that this protein isn't the best research target. “We're disappointed that the treatment did not ...

Article found on: www.biopharmadive.com

View Original Article